Cencora's Revenue Surges by 10.9% YoY in Q3 2024, Showing Robust Growth Trend
Cencora, Inc. [COR] reported a strong performance in the fiscal quarter ending June 30, 2024. The company announced a net profit of $483 million for the quarter, marking a notable increase from the previous quarter.
The company, headquartered in Conshohocken, Pennsylvania, reported to SEC in an 8-K filing $2.42 earnings per share in the quarter, compared to $2.35 in the previous quarter.
Cencora, a prominent player in the pharmaceuticals sector, reported a revenue of $74.2 billion in the recent period. This figure demonstrates a substantial increase compared to the revenue generated in the previous quarter.
In comparing the current quarter's revenue to the same quarter in the previous year, Cencora witnessed a significant increase, showcasing a growth trajectory in its financial performance. Additionally, the company experienced a notable percentage change in profit for the current quarter when juxtaposed with the profit in the same quarter of the previous year.
Sponsored
As of August 18, 2023 end of day trading.
Dollars in millions | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|
Income Statement |
| Revenue | $74,241.4 | $72,252.8 | $262,173.4 | $66,947.0 |
| Operating Profit | $672.5 | $822.9 | $2,340.7 | $670.1 |
| Net Income | $487.6 | $603.0 | $1,732.6 | $479.2 |
| Net Cash | $723.5 | $283.2 | -$840.7 | -$2,045.3 |
| Gross Margin | $2,410.8 | $2,468.8 | $8,959.5 | $2,264.6 |
| Operating Margin | $0.0 | $0.0 | $0.0 | $0.0 |
| Profit as % of Revenues | 494.42 | 409.42 | 517.12 | 472.58 |
| Profit as % of Assets | 0.69 | 0.88 | 1.07 | 0.75 |
| Profit as % of Stockholder Equity | 45.98 | 56.82 | 260.03 | 51.97 |
| Return on Equity | 45.98 | 56.82 | 260.03 | 51.97 |
| Return on Assets | 0.73 | 0.93 | 2.77 | 0.78 |
| Turnover Ratio | 105.30 | 105.52 | 161.47 | 104.50 |
| EBITA | $945.1 | $1,093.5 | $3,304.6 | $944.4 |
Balance Sheet |
| Total Assets | $66,772.4 | $64,690.3 | $62,558.7 | $61,177.2 |
| Total Liabilities | $65,711.9 | $63,629.0 | $61,892.5 | $60,255.2 |
Cash Flow Statement |
| Operating Cash Flow | $2,484.3 | $885.2 | $3,911.3 | $2,084.5 |
| Investing Cash Flow | -$376.2 | -$65.8 | -$2,602.5 | -$2,419.0 |
| Financing Cash Flow | -$1,373.7 | -$551.7 | -$2,222.3 | -$1,815.3 |
USinMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. Although we take care to ensure accuracy, the article does not intend to replace user diligence in decisions of financial or legal implications. Sponsored
